GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · IEX Real-Time Price · USD
2.880
+0.220 (8.27%)
At close: Jul 2, 2024, 4:00 PM
2.820
-0.060 (-2.08%)
After-hours: Jul 2, 2024, 7:29 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $6.21 million as of July 2, 2024. Its market cap has decreased by -46.91% in one year.
Market Cap
6.21M
Enterprise Value
-3.57M
1-Year Change
-46.91%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $6.21M, a decrease of -92.53%. That is a compound annual growth rate of -33.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 4.10M | -61.32% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NuCana | 6.07M |
| Notable Labs | 5.99M |
| Oragenics | 5.92M |
| IM Cannabis | 5.91M |
| Tenax Therapeutics | 5.82M |
| Intelligent Bio Solutions | 5.70M |
| Hepion Pharmaceuticals | 5.68M |
| SunLink Health Systems | 5.63M |